Compile Data Set for Download or QSAR
maximum 50k data
Found 55 with Last Name = 'kobal' and Initial = 'b'
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229602(US9340506, A-1)
Affinity DataEC50:  1.40E+3nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM50615270(CHEMBL5274471)
Affinity DataEC50:  690nMAssay Description:Activation of recombinant human glucokinase assessed as increase in maximal activation by measuring accumulation of NADH in presence of S0.5 of gluco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229604(US9340506, A-12)
Affinity DataEC50:  660nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229605(US9340506, A-32)
Affinity DataEC50: >1.00E+4nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229606(US9340506, A-58)
Affinity DataEC50: >1.00E+4nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229607(US9340506, B-4)
Affinity DataEC50:  3.70E+3nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229608(US9340506, B-9)
Affinity DataEC50:  93nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM228462(BDBM229609 | US9340506, G3B)
Affinity DataEC50:  1.12E+3nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229610(US9340506, B-20)
Affinity DataEC50:  590nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229611(US9340506, B-23)
Affinity DataEC50:  480nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229612(US9340506, B-26)
Affinity DataEC50:  220nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229613(US9340506, B-49)
Affinity DataEC50:  570nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229614(US9340506, B-58)
Affinity DataEC50:  740nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229615(US9340506, C3)
Affinity DataEC50:  130nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229616(US9340506, D1)
Affinity DataEC50:  100nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM228475(BDBM229617 | US9340506, G20A)
Affinity DataEC50:  140nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229618(US9340506, E2)
Affinity DataEC50:  1.50E+3nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229619(US9340506, E3)
Affinity DataEC50:  1.20E+3nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM228461(BDBM229620 | US9340506, G1B)
Affinity DataEC50:  87nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM228461(BDBM229620 | US9340506, G1B)
Affinity DataEC50:  330nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM228462(BDBM229609 | US9340506, G3B)
Affinity DataEC50:  420nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM228464(BDBM229621 | US9340506, G4B)
Affinity DataEC50:  260nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM228464(BDBM229621 | US9340506, G4B)
Affinity DataEC50:  640nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229622(US9340506, G5A)
Affinity DataEC50:  94nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229623(US9340506, G8A)
Affinity DataEC50:  190nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229624(US9340506, G9A)
Affinity DataEC50:  270nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229625(US9340506, G10A)
Affinity DataEC50:  230nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229626(US9340506, G11A)
Affinity DataEC50:  570nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229627(US9340506, G12A)
Affinity DataEC50:  300nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229628(US9340506, G14A)
Affinity DataEC50:  380nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229629(US9340506, G15A)
Affinity DataEC50:  480nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229630(US9340506, G16A)
Affinity DataEC50:  270nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229631(US9340506, G19A)
Affinity DataEC50:  100nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM228475(BDBM229617 | US9340506, G20A)
Affinity DataEC50:  64nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229632(US9340506, G22A)
Affinity DataEC50:  290nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229633(US9340506, G25A)
Affinity DataEC50:  200nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229634(US9340506, G26A)
Affinity DataEC50:  180nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM229635(US9340506, G27A)
Affinity DataEC50:  130nMpH: 7.2Assay Description:The assay is carried out according to the protocol outlined in Hariharan et al (1997), Diabetes 46: 11-16. Briefly, the test compounds are incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM50615254(CHEMBL5278201)
Affinity DataEC50:  7.00E+3nMAssay Description:Activation of recombinant human glucokinase assessed as increase in maximal activation by measuring accumulation of NADH in presence of S0.5 of gluco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM50615255(CHEMBL5282130)
Affinity DataEC50:  6.20E+3nMAssay Description:Activation of recombinant human glucokinase assessed as increase in maximal activation by measuring accumulation of NADH in presence of S0.5 of gluco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM50615256(CHEMBL5285032)
Affinity DataEC50:  500nMAssay Description:Activation of recombinant human glucokinase assessed as increase in maximal activation by measuring accumulation of NADH in presence of S0.5 of gluco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM50615257(CHEMBL5275454)
Affinity DataEC50: >2.00E+4nMAssay Description:Activation of recombinant human glucokinase assessed as increase in maximal activation by measuring accumulation of NADH in presence of S0.5 of gluco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM50615258(CHEMBL5287945)
Affinity DataEC50:  280nMAssay Description:Activation of recombinant human glucokinase assessed as increase in maximal activation by measuring accumulation of NADH in presence of S0.5 of gluco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM50615259(CHEMBL5287339)
Affinity DataEC50:  330nMAssay Description:Activation of recombinant human glucokinase assessed as increase in maximal activation by measuring accumulation of NADH in presence of S0.5 of gluco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM50615260(CHEMBL5290632)
Affinity DataEC50:  240nMAssay Description:Activation of recombinant human glucokinase assessed as increase in maximal activation by measuring accumulation of NADH in presence of S0.5 of gluco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM50615261(CHEMBL5266463)
Affinity DataEC50:  190nMAssay Description:Activation of recombinant human glucokinase assessed as increase in maximal activation by measuring accumulation of NADH in presence of S0.5 of gluco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM50615262(CHEMBL5282187)
Affinity DataEC50:  310nMAssay Description:Activation of recombinant human glucokinase assessed as increase in maximal activation by measuring accumulation of NADH in presence of S0.5 of gluco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM50615263(CHEMBL5275999)
Affinity DataEC50:  2.73E+3nMAssay Description:Activation of recombinant human glucokinase assessed as increase in maximal activation by measuring accumulation of NADH in presence of S0.5 of gluco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM50615264(CHEMBL5288114)
Affinity DataEC50:  400nMAssay Description:Activation of recombinant human glucokinase assessed as increase in maximal activation by measuring accumulation of NADH in presence of S0.5 of gluco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetHexokinase-4(Homo sapiens (Human))
Advinus Therapeutics

US Patent
LigandPNGBDBM50615265(CHEMBL5276863)
Affinity DataEC50:  450nMAssay Description:Activation of recombinant human glucokinase assessed as increase in maximal activation by measuring accumulation of NADH in presence of S0.5 of gluco...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
Displayed 1 to 50 (of 55 total ) | Next | Last >>
Jump to: